Skip to main content
Fig. 4 | Experimental Hematology & Oncology

Fig. 4

From: IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

Fig. 4

Comparison of prognostic model discrimination in patients with MDS. Model discrimination as measured by the C-statistics obtained with IPSS-R or IPSS-M categories on overall survival in the whole cohort, age < 60 years cohort and age ≥ 60 years cohort. Abbreviations: IPSS-R: International Prognostic Scoring System-Revised; IPSS-M: International Prognostic Scoring System-Molecular; CI: confidence interval

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us